Trump Executive Order Leaves AI Firms Stuck in Regulatory Limbo

Trump Executive Order Leaves AI Firms Stuck in Regulatory Limbo

Sarah Mitchell

Written by

Sarah Mitchell

If you think the biggest threat to the future of American artificial intelligence is a new set of rules, you’re missing the point. The industry is currently locked in a high-stakes standoff, fueled by the belief that any regulation is a death knell for innovation. But the real story here isn't the presence or absence of government oversight—it’s the corrosive, paralyzing effect of uncertainty.

Last fall, President Trump signed an executive order with the stated goal of keeping AI companies “free to innovate without cumbersome regulation.” To achieve this, the administration established an AI Litigation Task Force designed to push back against state-level laws. They have even threatened to restrict funding from the Broadband Equity Access and Deployment (BEAD) Program for states that insist on implementing their own, potentially “onerous” rules. On the surface, this looks like a win for the “move fast and break things” crowd. In reality, it is a recipe for a market that is terrified to move at all.

The Myth of the Regulatory Bogeyman

The argument against regulation usually relies on a specific set of talking points: the impact of the EU’s General Data Protection Regulation (GDPR), broad comparisons between the U.S. and Europe, and the disproportionate cost burdens on smaller firms. It is true that the GDPR, which reshaped data handling, has been linked to negative impacts on innovation, with some research showing it diverted resources toward incremental improvements rather than radical breakthroughs. However, attributing this solely to the existence of rules is a convenient oversimplification.

When we look at the data, the picture is far murkier. Studies have shown that firms heavily exposed to EU markets experienced an average 8% decline in profits and a 2% reduction in sales following the GDPR. While this sounds like a clear indictment of regulation, researchers are quick to point out that measuring innovation is notoriously difficult. R&D spending, patent counts, and new product launches are all flawed proxies; they often fail to distinguish between a company spending money on actual creativity versus money spent just trying to figure out how to fill out a compliance form.

Why “Predictability” Is the Real Tech Currency

The tech sector often points to Europe’s 5% share of global AI computing capacity as proof that regulation kills growth. Yet, this ignores the structural reality that Europe lacks the venture capital depth and the consolidated legal regimes that allowed the U.S. to build its tech giants. When we blame regulation for everything, we ignore the fact that most startups fail because of poor product-market fit or leadership issues—not because of a privacy law.

For an ordinary user, this matters because "uncertainty" isn't just a boardroom problem; it’s a product problem. When a company doesn't know what the rules will be in six months, they stop building. We see this play out in medical technology, where firms introducing the first device in a new category spend about one-third longer in the U.S. approval process than their followers. That delay isn't caused by the safety standards themselves, but by the ambiguity of the path forward.

Navigating the Policy Patchwork

The executive order from last fall, while intended to clear the path for innovation, may paradoxically be creating the very environment that stifles it. By signaling a willingness to litigate against states and weaponize federal funding like the BEAD program, the administration is ensuring that the rules of the road remain in constant flux.

When firms can’t predict the cost of compliance, they don’t just innovate more—they retreat into a wait-and-see posture. They shift their focus from long-term, high-risk bets to short-term, safe improvements. True innovation requires a stable foundation, and currently, the floor is moving beneath everyone’s feet. The next reading of the U.S. Business R&D and Innovation Survey will show whether this climate of legal skirmishing and regulatory ambiguity has effectively cooled the appetite for the high-risk, high-reward research that defines the frontier of AI.

Earlier on this story

Our prior reporting on the people, places, and policies in this piece.

Share:
Sarah Mitchell

About the Author

Sarah Mitchell

Sarah Mitchell covers AI policy and consumer tech from Portland. Before OwlyTimes she spent five years building product at a developer-tools startup, which is where she stopped trusting demos. Writes when a feature ships, not when it's announced.

This article is based on reporting from the original source. OwlyTimes editors verified facts and added independent context.

Related Articles